1.15 USD
-0.01 (-0.86%)
1.12 USD
-0.03 (-2.61%)
ChartMill assigns a Buy % Consensus number of 46% to BOLD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is 166.09% above the current price.
BOLD was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about BOLD.
In the last month the buy percentage fell by 32 points. So the trust of analysts is decreasing.
BOLD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-02 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-28 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-12-13 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-04-22 | Leerink Partners | Initiate | Outperform |
| 2024-04-22 | Guggenheim | Initiate | Buy |
| 2024-04-22 | Piper Sandler | Initiate | Overweight |
BOUNDLESS BIO INC / BOLD FAQ
Can you provide the average price target for BOUNDLESS BIO INC stock?
7 analysts have analysed BOLD and the average price target is 3.06 USD. This implies a price increase of 166.09% is expected in the next year compared to the current price of 1.15.
Can you provide the consensus rating for BOUNDLESS BIO INC stock?
The consensus rating for BOUNDLESS BIO INC (BOLD) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for BOLD stock?
The number of analysts covering BOUNDLESS BIO INC (BOLD) is 7.